US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist

0.260
-0.016-5.76%

Close Feb 28 16:00 ET

0.270
+0.010+3.81%

Post 19:31 ET

7.85MMarket Cap-0.09P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relmada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Nov 7, 2024	2024/Q3	0.000 / 0.000	--
Aug 7, 2024	2024/Q2	0.000 / 0.000	--
May 8, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Nov 7, 20242024/Q30.000 / 0.000--

Aug 7, 20242024/Q20.000 / 0.000--

May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Relmada Therapeutics Earnings Reports

Relmada Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:10 ET

Relmada Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 16:10 ET

Relmada Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8, 2024 16:13 ET

Relmada Therapeutics | 8-K: Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Mar 19, 2024 16:14 ET